BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 03, 2007
 |  BioCentury  |  Strategy

EPO overlap

EPO overlap

U.S. patent Description Status under Dynepo suit Status under Mircera suit Comments
5,441,868 A process for producing glycosylated EPO polypeptides in mammalian cells transformed using heterologous recombination NA Undetermined Was not asserted in Dynepo suit
5,547,933...

Read the full 247 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >